Guoming Qi
Corporate Officer/Principal bei The Chinese Medical Association
Profil
Dr. Guoming Qi is Vice President at The Chinese Medical Association.
He is on the Board of Directors at China Medical Technologies, Inc.
Dr. Qi was previously employed as Vice President by Chinese Center For Disease Control & Prevention.
He received his undergraduate degree from Peking University, a graduate degree from the Chinese Academy of Medical Sciences, and a graduate degree from the Chinese Academy of Sciences.
Aktive Positionen von Guoming Qi
Unternehmen | Position | Beginn |
---|---|---|
The Chinese Medical Association | Corporate Officer/Principal | - |
Ehemalige bekannte Positionen von Guoming Qi
Unternehmen | Position | Ende |
---|---|---|
Chinese Center For Disease Control & Prevention | Corporate Officer/Principal | 01.01.1997 |
China Medical Technologies, Inc.
China Medical Technologies, Inc. Medical SpecialtiesHealth Technology China Medical Technologies, Inc. is a China-based medical device company. It develops, manufactures and markets vitro diagnostic products using enhanced chemiluminescence technology, fluorescent in situ hybridization technology and surface plasmon resonance technology to detect and monitor various diseases and disorders. The company was founded in July 1999 and is headquartered in Beijing, China. | Direktor/Vorstandsmitglied | - |
Ausbildung von Guoming Qi
Chinese Academy of Sciences | Graduate Degree |
Peking University | Undergraduate Degree |
Chinese Academy of Medical Sciences | Graduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Private Unternehmen | 3 |
---|---|
China Medical Technologies, Inc.
China Medical Technologies, Inc. Medical SpecialtiesHealth Technology China Medical Technologies, Inc. is a China-based medical device company. It develops, manufactures and markets vitro diagnostic products using enhanced chemiluminescence technology, fluorescent in situ hybridization technology and surface plasmon resonance technology to detect and monitor various diseases and disorders. The company was founded in July 1999 and is headquartered in Beijing, China. | Health Technology |
The Chinese Medical Association | |
Chinese Center For Disease Control & Prevention |